Download the latest version - Eastern Virginia Medical School
Download the latest version - Eastern Virginia Medical School Download the latest version - Eastern Virginia Medical School
DEPARTMENT OF OBSTETRICS AND GYNECOLOGY (CONTINUED)OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF A NEW LOW DOSE ORAL CONTRACEPTIVECONTAINING NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL Sponsor: Warner-ChilcottA DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY ASSESSING THE SAFETY ANDEFFICACY OF DVS SR FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITHMENOPAUSE Sponsor: WyethUSAID/FHI-PHARMACOKINETICS OF DEPO-SUBQ INJECTED IN UPPER ARM Sponsor:NICHD-NIH/TASK 4-TORFP-PATH FEMALE CONDOM Sponsor:SOLVAY/PROMETRIUM-S168400 Sponsor: CorporateEFFICACY AND SAFETY OF NORETHINDRONE ACETATE TRANSDERMAL DELIVERY SYSTEM Sponsor:GSK/VASOMOTOR SYMPTOMS GS Sponsor: CorporateBAYER/TRANSDERMAL CONTRACEPTIVE PATCH/91555 Sponsor: CorporateWYETH-EVALUATION OF CHANGES IN MAMMOGRAPHIC BREAST DENSITY Sponsor: CorporateWYETH-ENDOMETRIAL HYPERPLASIA & PREVENTION OF OSTEOPORTSIS Sponsor: CorporateBOCCA, Silvinia M., M.D., Ph.D.IMMUNODULATORY GENES & PROTEINS Sponsor: JIF-OBGYNULTASOUND COMPARED TO IMAGING MODALITIES IN WOMEN Sponsor: AIUM/KIMBLE, Thomas, M.D.MEASURING THE ACTIVITIES OF CYP3A4 AND CYP2C9, MEMBERS OF THE CYTOCHROME P-450FAMILY TO PREDICT EXCESSIVE BONE LOSS IN YOUNG WOMEN THAT USE DEPOTMEDROXYPROGESTERONE ACETATE Sponsor: Department of OB/GYN, EVMSI-TEVA/DR-103 FOR PREVENTION OF PREGNANCY/DR-103-301 Sponsor:MED 360/SYNTERACT-LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM Sponsor:THE EFFECT OF CONTINUOUS LEVONORGESTREL ON ENDOMETRIAL CAVITY CYTOKINES ANDGROWH FACTORS IN WOMEN WITH UTERINE FIBROIDS Sponsor: BAYER/WH-2010-10/NUVARING STUDY Sponsor: SCHERING PLOUGH120
DEPARTMENT OF OBSTETRICS AND GYNECOLOGY (CONTINUED)LUKBAN, James, D.O.A PROSPECTIVE, MULTI-CENTER STUDY TO ASSESS THE AMS PELVIC FLOOR REPAIR SYSTEMDEVICES FOR PROLAPSE REPAIR. Sponsor: American Medical SystemsLONG-TERM EFFECTIVENESS TRIAL FOR AMS SLING SYSTEMS Sponsor: American Medical SystemsTHREE-DIMENSIONAL ULTRASOUND EVALUATION OF THE FEMALE PELVIC FLOOR: ACHARACTERIZATION OF NORMAL AND ABNORMAL STRUCTURAL AND SPHINCTERIC ANATOMY Sponsor: Department of OB/GYN, EVMSDURAMED/ EFFICACY OF DR-3001/DR-OXY-301-SUB Sponsor:TREATMENT FOR FEMALE STRESS URINARY INCONTINENCE IN WOMEN Sponsor: NOVASYS/RENESSAOEHNINGER, Sergio C., M.D.PROTEOME/METABOLOME OF IN-VITRO CULTURED MURINE BLASTOCYSTS Sponsor: SCHERING-PLOUGHJIF-OBGYN/HUMAN EMBRYO DEVELOPMENTAL POTENTIAL IN IVF Sponsor:SAKHEL, Khaled, M.D.MEDROXY PROG ESTERONE ACETATE/WS377470 Sponsor: PFIZER/ DEPOTHOLOGIC-ULTRASOUND REPLACEMENT FOR THE HSG-BASED ADIANA CONFIRMATION TEST Sponsor:STADTMAUER, Laurel, M.D., Ph.D.STRATEGIES TO REDUCE RISK OF MULTIPLE BIRTHS Sponsor: ORGANONI-NOVARTIS/ORAL BGS649 vs PLACEBO Sponsor:DURAMED/ DR-PGN-302-LUTEAL PHASE SUPPLEMENTATION Sponsor:THURMAN, Andrea, M.D.SAFETY AND EFFICACY OF WC2031 VERSUS VIBRAMYCIN FOR THE TREATMENT OF UNCOMPLICATEDUROGENITAL AND CHLAMYDIA TRACHOMATIS INFECTION: A RANDOMIZED, DOUBLE-BLINE, DOUBLE-DUMMY, ACTIVE-CONTROLLED, MULTI-CENTER STUDY. PROTOCOL: 4809 Sponsor:WARSOF, Steven, M.D.MELISSA STUDY: MATERNAL BLOOD IS SOURCE TO ACCURATELY DIAGNOSE FETAL ANEUPLOIDY. APERSPECTIVE, MULTI-CENTER OBSERVATIONAL STUDY WITH BLINDED, NESTED CASE: CONTROLANALYSES TO EVALUATE THE PERFORMANCE OF THE ARTEMIS HEALTH PRENATAL ANEUPLOIDYDIAGNOSTIC TEST Sponsor:121
- Page 73 and 74: This page intentionally left blank.
- Page 75 and 76: EMPLOYEE OCCUPATIONAL CATEGORY BY G
- Page 77 and 78: EMPLOYEE OCCUPATIONAL CATEGORY BY R
- Page 79 and 80: LIBRARYSource: EVMS Associate Dean
- Page 81 and 82: LIBRARY COLLECTION RESOURCESVOLUMES
- Page 83 and 84: LIBRARY SERVICESINTERLIBRARY LOANSA
- Page 85 and 86: PHYSICAL PLANTSource: Director, Aux
- Page 87 and 88: PHYSICAL PLANT INVENTORY2011Buildin
- Page 89 and 90: RESOURCES85
- Page 91 and 92: SOURCES OF REVENUESource of Income
- Page 93 and 94: SOURCES OF GENERAL REVENUEMillions7
- Page 95 and 96: EXTRAMURAL PROGRAM SUPPORT91
- Page 97 and 98: EXTRAMURAL SPONSORED PROGRAMSBASIC
- Page 99 and 100: EXTRAMURAL SPONSORED PROGRAMSSCHOOL
- Page 101 and 102: TOTAL EXTRAMURAL PROGRAM FUNDING FY
- Page 103 and 104: EXTRAMURAL FUNDING: ALL DEPARTMENTS
- Page 105 and 106: FUNDED PROGRAMS101
- Page 107 and 108: ADMINISTRATIVE DEPARTMENTS Funded P
- Page 109 and 110: SCHOOL OF HEALTH PROFESSIONSVice Pr
- Page 111 and 112: DEPARTMENT OF DERMATOLOGYChair:Prof
- Page 113 and 114: DEPARTMENT OF FAMILY AND COMMUNITY
- Page 115 and 116: DEPARTMENT OF INTERNAL MEDICINEChai
- Page 117 and 118: DEPARTMENT OF INTERNAL MEDICINE (CO
- Page 119 and 120: DEPARTMENT OF MICROBIOLOGY AND MOLE
- Page 121 and 122: DEPARTMENT OF MICROBIOLOGY AND MOLE
- Page 123: DEPARTMENT OF OBSTETRICS AND GYNECO
- Page 127 and 128: DEPARTMENT OF OTOLARYNGOLOGY - HEAD
- Page 129 and 130: DEPARTMENT OF PEDIATRICSChair:Vice-
- Page 131 and 132: DEPARTMENT OF PHYSICAL MEDICINE & R
- Page 133 and 134: DEPARTMENT OF PHYSIOLOGICAL SCIENCE
- Page 135 and 136: DEPARTMENT OF RADIATION ONCOLOGY AN
- Page 137 and 138: DEPARTMENT OF SURGERYChair:Professo
- Page 139 and 140: SOURCES OF FUNDED PROGRAMSAbbott La
- Page 141 and 142: SOURCES OF FUNDED PROGRAMS (continu
- Page 143 and 144: SOURCES OF FUNDED PROGRAMS (continu
- Page 145 and 146: CENTERS OF EXCELLENCESource: www.ev
- Page 147 and 148: THE CARDIOVASCULAR AND RENAL RESEAR
- Page 149 and 150: the hundreds of billions of dollars
- Page 151 and 152: Educate Hampton Roads patients, hea
- Page 153 and 154: THE VOICE CENTERThe Voice Center pr
- Page 155 and 156: PUBLICATIONS BY EVMS FACULTYSource:
- Page 157 and 158: FACULTY PUBLICATIONSABUHAMAD A, Gro
- Page 159 and 160: FACULTY PUBLICATIONS (continued)Boy
- Page 161 and 162: FACULTY PUBLICATIONS (continued)DEU
- Page 163 and 164: FACULTY PUBLICATIONS (continued)GIL
- Page 165 and 166: FACULTY PUBLICATIONS (continued)Ket
- Page 167 and 168: FACULTY PUBLICATIONS (continued)NEU
- Page 169 and 170: FACULTY PUBLICATIONS (continued)Sic
- Page 171 and 172: FACULTY PUBLICATIONS (continued)VIN
- Page 173 and 174: KEY REGULATORY REQUIREMENTSSource:
DEPARTMENT OF OBSTETRICS AND GYNECOLOGY (CONTINUED)OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF A NEW LOW DOSE ORAL CONTRACEPTIVECONTAINING NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL Sponsor: Warner-ChilcottA DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY ASSESSING THE SAFETY ANDEFFICACY OF DVS SR FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITHMENOPAUSE Sponsor: WyethUSAID/FHI-PHARMACOKINETICS OF DEPO-SUBQ INJECTED IN UPPER ARM Sponsor:NICHD-NIH/TASK 4-TORFP-PATH FEMALE CONDOM Sponsor:SOLVAY/PROMETRIUM-S168400 Sponsor: CorporateEFFICACY AND SAFETY OF NORETHINDRONE ACETATE TRANSDERMAL DELIVERY SYSTEM Sponsor:GSK/VASOMOTOR SYMPTOMS GS Sponsor: CorporateBAYER/TRANSDERMAL CONTRACEPTIVE PATCH/91555 Sponsor: CorporateWYETH-EVALUATION OF CHANGES IN MAMMOGRAPHIC BREAST DENSITY Sponsor: CorporateWYETH-ENDOMETRIAL HYPERPLASIA & PREVENTION OF OSTEOPORTSIS Sponsor: CorporateBOCCA, Silvinia M., M.D., Ph.D.IMMUNODULATORY GENES & PROTEINS Sponsor: JIF-OBGYNULTASOUND COMPARED TO IMAGING MODALITIES IN WOMEN Sponsor: AIUM/KIMBLE, Thomas, M.D.MEASURING THE ACTIVITIES OF CYP3A4 AND CYP2C9, MEMBERS OF THE CYTOCHROME P-450FAMILY TO PREDICT EXCESSIVE BONE LOSS IN YOUNG WOMEN THAT USE DEPOTMEDROXYPROGESTERONE ACETATE Sponsor: Department of OB/GYN, EVMSI-TEVA/DR-103 FOR PREVENTION OF PREGNANCY/DR-103-301 Sponsor:MED 360/SYNTERACT-LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM Sponsor:THE EFFECT OF CONTINUOUS LEVONORGESTREL ON ENDOMETRIAL CAVITY CYTOKINES ANDGROWH FACTORS IN WOMEN WITH UTERINE FIBROIDS Sponsor: BAYER/WH-2010-10/NUVARING STUDY Sponsor: SCHERING PLOUGH120
Change language